SCHEMBL10924722

SCHEMBL10924722

Cc1onc(-c2ccccc2)c1-c1[nH]c2ccc(F)cc2c1CCC(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 4/20 0.46
TACR1 P25103 1/20 0.46
PTGDR2 Q9Y5Y4 1/20 0.45
EGFR P00533 2/20 0.44
CSF1R P07333 1/20 0.43
THRB P10828 1/20 0.43
MAP2 P11137 1/20 0.43
SRC P12931 1/20 0.42
GAA P10253 3/20 0.42
TSHR P16473 1/20 0.42
MGAM O43451 2/20 0.41
SI P14410 2/20 0.41
MGAM2 Q2M2H8 2/20 0.41
MAPT P10636 2/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
PTGS1 P23219 1/20 0.41
PTGS2 P35354 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10924963 0.89 EGFR (0.51) PPARGEGFRSRCGAAMAPT
SCHEMBL10923170 0.87 CSF1R (0.44) PTGDR2CSF1RTHRBMAP2GAA
SCHEMBL10832252 0.85 HTR6 (0.49) CSF1RGAAMGAMSIMGAM2
SCHEMBL10832255 0.85 HTR6 (0.46) CSF1RGAAMGAMSIMGAM2
SCHEMBL10922515 0.83 CYP1A2 (0.44) PTGDR2CSF1RTHRBGAAMGAM
SCHEMBL10832434 0.82 GAA (0.47) PTGDR2CSF1RMAP2GAATSHR
SCHEMBL6929600 0.81 PPARG (0.66) PPARGTACR1EGFRMAP2SRC
SCHEMBL10831709 0.80 MAPT (0.43) PTGDR2CSF1RTHRBMAP2GAA
SCHEMBL10924718 0.80 CSF1R (0.44) PTGDR2CSF1RTHRBMAP2GAA
SCHEMBL11054385 0.80 CSF1R (0.46) PTGDR2CSF1RMAP2GAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4536499-A Isoxazolyl indolamines having anti-diabetic activity SANDOZ, INC. (US) 1985-08-20 US disclosed